BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, February 25, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 23, 2000

View Archived Issues

NIH grant for acute lung injury research goes to CollaGenex

Read More

Interferon Sciences acquires option to purchase 50% of Metacine stock

Read More

Oncophage enters phase II sarcoma study; trial marks drug's seventh cancer indication

Read More

Lilly terminates (R)-fluoxetine license agreement with Sepracor

Read More

TroVax colorectal cancer vaccine approved for phase I/II

Read More

FDA grants priority review status for pulmonary hypertension NDA

Read More

Celebrex introduced in major European market

Read More

Interim data from AIDS dementia complex trial of CPI-1189 announced

Read More

DuPont designs novel template-constrained cyclic peptide somatostatin analogues

Read More

Active enantiomers of new thiourea NNRTIs effective against resistant HIV strains

Read More

Long-acting subdermal contraceptive implant now available in Germany

Read More

Antitumor activity and mechanism of action of new Hsp90 inhibitor examined in preclinical studies

Read More

Encouraging data reported for Emitasol in diabetic gastroparesis

Read More

G207 studied further for anticancer, antimetastatic potential

Read More

Protective effect demonstrated for SKK-60060 in rat model of retinal ischemia-reperfusion

Read More

Coley begins phase II trials with CpG compound

Read More

SmithKline Beecham exercises development option for HGS compound

Read More

MDR-reversing pyripyropene characterized at Japanese Cancer Association meeting

Read More

SkyePharma's Solaraze earns FDA approval

Read More

Orally active plant-derived peptide with hypoglycemic activity

Read More

Vivus withdraws Alibra NDA

Read More

Novel anthracyclines designed by Menarini display excellent antitumor activity

Read More

Italian scientists discover antitumor agents particularly useful in colon cancer

Read More

Sankyo's new therapeutics for Alzheimer's disease display dual actions

Read More

NK1 receptor antagonists useful for CNS disorders reported by Roche

Read More

Pharmacia identifies new herpesvirus polymerase inhibitors

Read More

Imidazole-based H3 receptor antagonists and their use patented by Schering-Plough

Read More

Popular Stories

  • Today's news in brief

    BioWorld
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • Pill in immersive interface

    New mechanism of action identified for QC-6352

    BioWorld Science
    QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
  • Illustration of brain and antibodies

    VST Bio’s VB-001 is neuroprotector after stroke

    BioWorld Science
    At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing